Expression of RPL10 in glioma - The Human Protein Atlas

GLIOBLASTOMA MULTIFORME (TCGA) - Interactive survival scatter plotⁱ

The Survival Scatter plot shows the clinical status (i.e. dead or alive) for all individuals in the patient cohort, based on the same data that underlies the corresponding Kaplan-Meier plots. Patients that are alive at last time for follow-up are shown in blue and patients who have died during the study are shown in red.

The x-axis shows the expression levels (FPKM) of the investigated gene in the tumor tissue at the time of diagnosis. The y-axis shows the follow-up time after diagnosis (years). Both axes are complimented with kernel density curves demonstrating the data density over the axes. The top density plot shows the expression levels (FPKM) distribution among dead (red) and alive patients (blue). The right density plot shows the data density of the survived years of dead patients with high and low expression levels respectively, stratified using the cutoff indicated by the vertical dashed line through the Survival Scatter plot. This cutoff is automatically defined based on the FPKM cutoff that minimizes the p-score. The cutoff can be changed by dragging the vertical line or by entering a cutoff value in the square labeled "Current cut-off".

Under the Survival Scatter plot the p-score landscape (black curve; left axis) is shown together with dead median separation (red curve; right axis). Dead median separation is the difference in median mRNA expression between patients who have died with high and low expression, respectively. It is calculated as follows: median FPKM expression of dead patients with high expression - median FPKM expression of dead patients with low expression. This is intended to aid the user in visually exploring custom cutoffs and the associated p-scores and dead median separation.

Individual patient data is displayed and can be filtered by clicking on one or more of the category buttons on the top of the page. Categories describing expression level and patient information include: high, low, alive, dead, female, male and tumor stages. The scale of the x-axis can be toggled between linear and log-scale by clicking on the "x log" button. Mouse-over function shows TCGA ID, patient information and mRNA expression (FPKM) for each patient.

& Survival analysisⁱ

RPL10 is not prognostic in Glioblastoma Multiforme (TCGA)

Stage:

Survival analysis

Current cut offⁱ :

Best expression cut offⁱ : 2962.23

Median expressionⁱ : N/A

Median follow up timeⁱ : N/A

P scoreⁱ N/A

3-year survival highⁱ N/A

3-year survival lowⁱ N/A

TCGA RNA samplesⁱ

Average pTPM

2980.7

Number of samples

141

Samples

Sample	Description	pTPM
TCGA-12-3650-01A	46 years, male, white, stage:'--, dead, 333 days	8437.3
TCGA-14-0871-01A	74 years, female, white, stage:'--, dead, 880 days	8349.9
TCGA-28-5218-01A	63 years, male, white, stage:'--, dead, 157 days	7907.9
TCGA-06-0178-01A	38 years, male, white, stage:'--, dead, 2681 days	6228.3
TCGA-02-2483-01A	43 years, male, asian, stage:'--, alive, 466 days	5629.9
TCGA-14-0817-01A	69 years, female, white, stage:'--, dead, 164 days	5579.9
TCGA-14-2554-01A	52 years, female, white, stage:'--, dead, 532 days	5353.7
TCGA-06-0129-01A	30 years, male, asian, stage:'--, dead, 1024 days	5224.9
TCGA-12-3652-01A	60 years, male, white, stage:'--, dead, 1062 days	4921.5
TCGA-02-0055-01A	62 years, female, white, stage:'--, dead, 76 days	4597.0
TCGA-27-2521-01A	34 years, male, white, stage:'--, dead, 510 days	4424.1
TCGA-06-2569-01A	24 years, female, black or african american, stage:'--, alive, 13 days	4380.3
TCGA-28-2509-01A	77 years, female, white, stage:'--, alive, 145 days	4155.5
TCGA-12-0821-01A	62 years, male, white, stage:'--, dead, 323 days	4133.0
TCGA-14-1823-01A	58 years, female, white, stage:'--, dead, 543 days	3944.1
TCGA-27-2524-01A	56 years, male, white, stage:'--, dead, 231 days	3840.7
TCGA-41-5651-01A	59 years, female, black or african american, stage:'--, dead, 460 days	3784.0
TCGA-06-0174-01A	54 years, male, white, stage:'--, dead, 98 days	3781.8
TCGA-06-5417-01A	45 years, female, white, stage:'--, alive, 155 days	3630.8
TCGA-19-4065-01A	36 years, male, white, stage:'--, alive, 214 days	3579.1
TCGA-19-5960-01A	56 years, male, white, stage:'--, dead, 455 days	3540.6
TCGA-12-5299-01A	56 years, female, white, stage:'--, dead, 98 days	3531.5
TCGA-76-4932-01A	50 years, female, white, stage:'--, dead, 1458 days	3528.7
TCGA-06-0210-01A	72 years, female, white, stage:'--, dead, 225 days	3517.6
TCGA-06-0190-01A	62 years, male, white, stage:'--, dead, 317 days	3466.5
TCGA-06-0139-01A	40 years, male, white, stage:'--, dead, 362 days	3437.1
TCGA-06-2570-01A	21 years, female, white, stage:'--, alive, 958 days	3402.0
TCGA-32-5222-01A	66 years, male, white, stage:'--, dead, 585 days	3390.6
TCGA-41-2571-01A	89 years, male, white, stage:'--, dead, 26 days	3383.3
TCGA-41-3915-01A	48 years, male, white, stage:'--, dead, 360 days	3303.8
TCGA-76-4927-01A	58 years, male, white, stage:'--, dead, 535 days	3276.7
TCGA-06-0745-01A	59 years, male, white, stage:'--, dead, 239 days	3259.7
TCGA-27-2528-01A	62 years, male, white, stage:'--, dead, 480 days	3255.9
TCGA-27-2526-01A	79 years, female, white, stage:'--, dead, 87 days	3241.9
TCGA-06-0645-01A	55 years, female, white, stage:'--, dead, 175 days	3241.7
TCGA-28-5216-01A	52 years, male, white, stage:'--, alive, 415 days	3233.0
TCGA-27-2523-01A	63 years, male, white, stage:'--, dead, 489 days	3229.6
TCGA-06-0211-01A	47 years, male, white, stage:'--, dead, 360 days	3224.2
TCGA-06-0686-01A	53 years, male, white, stage:'--, dead, 432 days	3219.1
TCGA-06-0744-01A	66 years, male, white, stage:'--, dead, 1426 days	3216.2
TCGA-12-5295-01A	60 years, female, white, stage:'--, dead, 454 days	3203.0
TCGA-02-2485-01A	53 years, male, black or african american, stage:'--, alive, 470 days	3182.7
TCGA-12-0616-01A	36 years, female, white, stage:'--, dead, 448 days	3180.0
TCGA-06-5858-01A	45 years, female, white, stage:'--, alive, 187 days	3150.8
TCGA-27-1831-01A	66 years, male, white, stage:'--, dead, 505 days	3150.7
TCGA-32-2632-01A	80 years, male, white, stage:'--, dead, 269 days	3105.0
TCGA-32-4213-01A	47 years, female, white, stage:'--, alive, 604 days	3101.9
TCGA-02-2486-01A	64 years, male, white, stage:'--, dead, 618 days	3095.5
TCGA-06-0238-01A	46 years, male, white, stage:'--, dead, 405 days	3091.2
TCGA-32-2638-01A	67 years, male, white, stage:'--, dead, 766 days	3090.9
TCGA-12-3653-01A	34 years, female, white, stage:'--, dead, 442 days	3085.5
TCGA-06-5416-01A	23 years, female, white, stage:'--, alive, 204 days	3070.4
TCGA-28-5208-01A	52 years, male, white, stage:'--, dead, 544 days	3058.1
TCGA-06-5413-01A	67 years, male, white, stage:'--, alive, 268 days	3052.3
TCGA-06-0130-01A	54 years, male, white, stage:'--, dead, 394 days	3049.4
TCGA-06-0184-01A	63 years, male, white, stage:'--, dead, 2126 days	3049.4
TCGA-19-1390-01A	63 years, female, white, stage:'--, dead, 772 days	3036.8
TCGA-26-5132-01A	74 years, male, white, stage:'--, alive, 286 days	3027.2
TCGA-06-2563-01A	72 years, female, white, stage:'--, alive, 932 days	3027.1
TCGA-12-0618-01A	49 years, male, white, stage:'--, dead, 395 days	2999.9
TCGA-06-0138-01A	43 years, male, white, stage:'--, dead, 737 days	2971.0
TCGA-28-5207-01A	71 years, male, white, stage:'--, dead, 343 days	2953.5
TCGA-06-2559-01A	83 years, male, white, stage:'--, dead, 150 days	2944.9
TCGA-14-0789-01A	54 years, male, white, stage:'--, dead, 342 days	2921.8
TCGA-41-2572-01A	67 years, male, white, stage:'--, dead, 406 days	2920.0
TCGA-06-5408-01A	54 years, female, white, stage:'--, dead, 357 days	2919.8
TCGA-28-5204-01A	72 years, male, white, stage:'--, dead, 454 days	2883.2
TCGA-26-5133-01A	59 years, male, white, stage:'--, alive, 452 days	2848.0
TCGA-12-0619-01A	60 years, male, white, stage:'--, dead, 1062 days	2840.5
TCGA-06-5418-01A	75 years, female, white, stage:'--, dead, 83 days	2837.9
TCGA-15-0742-01A	65 years, male, white, stage:'--, dead, 419 days	2835.1
TCGA-76-4931-01A	70 years, female, white, stage:'--, dead, 279 days	2828.4
TCGA-28-5209-01A	66 years, female, white, stage:'--, alive, 442 days	2813.1
TCGA-06-0749-01A	50 years, male, black or african american, stage:'--, dead, 82 days	2799.0
TCGA-14-1034-01A	60 years, female, stage:'--, dead, 485 days	2796.5
TCGA-06-5856-01A	58 years, male, white, stage:'--, dead, 114 days	2769.7
TCGA-32-1982-01A	76 years, female, white, stage:'--, dead, 142 days	2761.0
TCGA-06-2565-01A	59 years, male, asian, stage:'--, dead, 506 days	2743.3
TCGA-06-0156-01A	57 years, male, white, stage:'--, dead, 178 days	2740.2
TCGA-76-4925-01A	76 years, male, white, stage:'--, dead, 146 days	2736.1
TCGA-14-1829-01A	57 years, male, black or african american, stage:'--, alive, 218 days	2726.9
TCGA-06-0219-01A	67 years, male, white, stage:'--, dead, 22 days	2723.1
TCGA-06-2558-01A	75 years, female, white, stage:'--, dead, 380 days	2712.7
TCGA-32-2615-01A	62 years, male, white, stage:'--, dead, 485 days	2671.6
TCGA-06-0158-01A	73 years, male, white, stage:'--, dead, 329 days	2651.1
TCGA-06-0168-01A	59 years, female, white, stage:'--, dead, 598 days	2617.2
TCGA-14-1825-01A	70 years, male, white, stage:'--, dead, 232 days	2612.6
TCGA-06-5410-01A	72 years, female, white, stage:'--, dead, 108 days	2598.1
TCGA-06-0132-01A	49 years, male, white, stage:'--, dead, 771 days	2594.3
TCGA-06-5414-01A	61 years, male, white, stage:'--, alive, 273 days	2588.9
TCGA-19-2629-01A	60 years, male, white, stage:'--, dead, 737 days	2586.0
TCGA-06-5412-01A	78 years, female, white, stage:'--, dead, 138 days	2541.8
TCGA-06-2562-01A	81 years, male, white, stage:'--, dead, 382 days	2479.2
TCGA-26-5139-01A	65 years, female, white, stage:'--, alive, 48 days	2478.3
TCGA-19-2620-01A	70 years, male, white, stage:'--, dead, 148 days	2476.3
TCGA-06-2557-01A	76 years, male, black or african american, stage:'--, dead, 33 days	2473.0
TCGA-14-0787-01A	69 years, male, asian, stage:'--, dead, 68 days	2472.0
TCGA-06-0644-01A	71 years, male, black or african american, stage:'--, dead, 384 days	2465.2
TCGA-28-5215-01A	62 years, female, white, stage:'--, dead, 335 days	2406.3
TCGA-26-5135-01A	72 years, female, white, stage:'--, dead, 270 days	2391.5
TCGA-06-0125-01A	63 years, female, white, stage:'--, dead, 1448 days	2378.1
TCGA-32-2634-01A	82 years, male, white, stage:'--, alive, 693 days	2371.1
TCGA-28-5220-01A	67 years, male, white, stage:'--, dead, 388 days	2370.5
TCGA-06-0747-01A	53 years, male, white, stage:'--, dead, 82 days	2369.5
TCGA-06-0187-01A	69 years, male, white, stage:'--, dead, 828 days	2364.6
TCGA-28-2513-01A	69 years, female, white, stage:'--, alive, 222 days	2355.4
TCGA-08-0386-01A	74 years, male, white, stage:'--, dead, 548 days	2318.4
TCGA-28-2514-01A	45 years, male, asian, stage:'--, alive, 160 days	2265.6
TCGA-06-2567-01A	65 years, male, white, stage:'--, dead, 133 days	2156.6
TCGA-32-1980-01A	72 years, male, white, stage:'--, dead, 36 days	2130.6
TCGA-26-1442-01A	43 years, male, white, stage:'--, alive, 953 days	2124.8
TCGA-06-0882-01A	30 years, male, white, stage:'--, dead, 632 days	2118.1
TCGA-28-1753-01A	53 years, male, white, stage:'--, alive, 37 days	2115.3
TCGA-06-5411-01A	51 years, male, white, stage:'--, dead, 254 days	2105.9
TCGA-76-4929-01A	76 years, female, white, stage:'--, dead, 111 days	2104.5
TCGA-27-1830-01A	57 years, male, white, stage:'--, dead, 154 days	2099.9
TCGA-19-2619-01A	55 years, female, black or african american, stage:'--, alive, 294 days	2094.7
TCGA-06-2564-01A	50 years, male, white, stage:'--, alive, 181 days	2082.6
TCGA-06-0878-01A	74 years, male, white, stage:'--, alive, 218 days	2050.9
TCGA-06-0750-01A	43 years, male, white, stage:'--, dead, 28 days	2011.4
TCGA-06-0646-01A	60 years, male, white, stage:'--, dead, 175 days	2001.8
TCGA-15-1444-01A	21 years, male, white, stage:'--, dead, 1537 days	1978.3
TCGA-27-1837-01A	36 years, male, white, stage:'--, dead, 427 days	1948.5
TCGA-32-1970-01A	59 years, male, white, stage:'--, dead, 468 days	1944.3
TCGA-06-5859-01A	63 years, male, white, stage:'--, alive, 139 days	1942.3
TCGA-02-0047-01A	78 years, male, white, stage:'--, dead, 448 days	1923.3
TCGA-27-1834-01A	56 years, male, white, stage:'--, dead, 1233 days	1915.6
TCGA-26-5134-01A	74 years, male, white, stage:'--, alive, 167 days	1901.4
TCGA-19-2625-01A	76 years, female, white, stage:'--, dead, 124 days	1877.0
TCGA-27-1832-01A	59 years, female, white, stage:'--, dead, 300 days	1842.8
TCGA-41-4097-01A	63 years, female, white, stage:'--, dead, 6 days	1842.6
TCGA-06-0157-01A	63 years, female, white, stage:'--, dead, 97 days	1833.2
TCGA-19-2624-01A	51 years, male, white, stage:'--, dead, 5 days	1812.5
TCGA-16-0846-01A	85 years, male, white, stage:'--, dead, 119 days	1787.2
TCGA-32-2616-01A	48 years, female, white, stage:'--, dead, 224 days	1779.0
TCGA-06-0141-01A	62 years, male, white, stage:'--, dead, 313 days	1715.3
TCGA-27-1835-01A	53 years, female, white, stage:'--, dead, 648 days	1701.3
TCGA-06-0743-01A	69 years, male, white, stage:'--, dead, 803 days	1570.4
TCGA-27-2519-01A	48 years, male, white, stage:'--, dead, 550 days	1515.6
TCGA-06-2561-01A	53 years, female, white, stage:'--, dead, 537 days	1487.3
TCGA-06-1804-01A	81 years, female, white, stage:'--, dead, 414 days	1258.5
Show allShow less

GLIOBLASTOMA MULTIFORME (VALIDATION) - Interactive survival scatter plotⁱ

& Survival analysisⁱ

RPL10 is potential prognostic, high expression is favorable in Glioblastoma Multiforme (validation)

Stage:

Survival analysis

Current cut offⁱ :

Best expression cut offⁱ : 266.33

Median expressionⁱ : N/A

Median follow up timeⁱ : N/A

P scoreⁱ N/A

3-year survival highⁱ N/A

3-year survival lowⁱ N/A

TCGA RNA samplesⁱ

Average pTPM

450.6

Number of samples

Samples

Sample	Description	pTPM
AK088	N, NA, stage:NA, dead, 360 days	994.9
AK142	N, NA, stage:NA, alive, 90 days	954.4
AK066	N, NA, stage:NA, alive, 960 days	909.2
AK165	N, NA, stage:NA, alive, 360 days	867.6
AK185	N, NA, stage:NA, alive, 330 days	847.9
AK072	N, NA, stage:NA, dead, 150 days	765.5
AK139	N, NA, stage:NA, dead, 270 days	694.1
AK178	N, NA, stage:NA, dead, 240 days	677.2
AK124	N, NA, stage:NA, alive, 1920 days	676.3
AK049	N, NA, stage:NA, dead, 180 days	666.3
AK074	N, NA, stage:NA, alive, 300 days	660.0
AK195	N, NA, stage:NA, dead, 390 days	635.2
AK213	N, NA, stage:NA, alive, 2010 days	630.1
AK055	N, NA, stage:NA, dead, 240 days	611.6
AK098	N, NA, stage:NA, dead, 660 days	610.2
AK188	N, NA, stage:NA, alive, 420 days	601.0
AK199	N, NA, stage:NA, alive, 1860 days	543.2
AK236	N, NA, stage:NA, dead, 360 days	508.4
AK227	N, NA, stage:NA, alive, 300 days	502.7
AK041	N, NA, stage:NA, alive, 810 days	501.2
AK183	N, NA, stage:NA, alive, 360 days	499.3
AK051	N, NA, stage:NA, dead, 360 days	484.8
AK231	N, NA, stage:NA, dead, 240 days	482.7
AK156	N, NA, stage:NA, dead, 330 days	476.4
AK100	N, NA, stage:NA, alive, 960 days	463.1
AK071	N, NA, stage:NA, dead, 540 days	459.8
AK043	N, NA, stage:NA, alive, 660 days	450.1
AK149	N, NA, stage:NA, dead, 420 days	447.1
AK076	N, NA, stage:NA, alive, 660 days	432.5
AK103	N, NA, stage:NA, alive, 1320 days	421.4
AK102	N, NA, stage:NA, alive, 1740 days	412.8
AK003	N, NA, stage:NA, dead, 600 days	396.5
AK167	N, NA, stage:NA, dead, 180 days	388.3
AK030	N, NA, stage:NA, dead, 120 days	387.6
AK158	N, NA, stage:NA, dead, 360 days	368.3
AK053	N, NA, stage:NA, dead, 300 days	361.8
AK091	N, NA, stage:NA, dead, 210 days	360.1
AK153	N, NA, stage:NA, dead, 240 days	353.4
AK002	N, NA, stage:NA, dead, 570 days	349.6
AK085	N, NA, stage:NA, alive, 660 days	349.1
AK089	N, NA, stage:NA, dead, 330 days	334.0
AK173	N, NA, stage:NA, dead, 180 days	327.5
AK216	N, NA, stage:NA, dead, 360 days	318.8
AK015	N, NA, stage:NA, alive, 720 days	315.9
AK133	N, NA, stage:NA, dead, 360 days	307.2
AK068	N, NA, stage:NA, alive, 360 days	270.3
AK035	N, NA, stage:NA, dead, 210 days	262.4
AK205	N, NA, stage:NA, dead, 120 days	247.2
AK117	N, NA, stage:NA, dead, 210 days	185.0
AK134	N, NA, stage:NA, dead, 360 days	181.8
AK218	N, NA, stage:NA, dead, 180 days	180.4
AK123	N, NA, stage:NA, dead, 180 days	166.1
AK079	N, NA, stage:NA, dead, 210 days	152.0
AK099	N, NA, stage:NA, dead, 420 days	150.5
AK081	N, NA, stage:NA, dead, 180 days	144.9
AK226	N, NA, stage:NA, dead, 360 days	143.8
AK005	N, NA, stage:NA, dead, 240 days	140.6
AK006	N, NA, stage:NA, dead, 360 days	108.8
Show allShow less

GLIOBLASTOMA MULTIFORME - Protein relative expression (CPTAC)

Number of samples

110

Samples

Sample ID	Sample type	nRPX
CPT0206560003	Tumor	0.8
CPT0127480003	Tumor	0.7
CPT0168080003	Tumor	0.7
CPT0182580003	Tumor	0.7
CPT0218330004	Tumor	0.6
CPT0224390004	Tumor	0.6
CPT0218830004	Tumor	0.5
CPT0218690004	Tumor	0.5
CPT0093450003	Tumor	0.5
CPT0206000004	Tumor	0.5
CPT0079790003	Tumor	0.4
CPT0093510003	Tumor	0.4
CPT0167640003	Tumor	0.4
CPT0168830003	Tumor	0.4
CPT0225760003	Tumor	0.4
CPT0168480003	Tumor	0.4
CPT0190360004	Tumor	0.4
CPT0221180003	Tumor	0.4
CPT0217430008	Tumor	0.4
CPT0078580003	Tumor	0.4
CPT0168590003	Tumor	0.4
CPT0206230003	Tumor	0.3
CPT0205450004	Tumor	0.3
CPT0217880003	Tumor	0.3
CPT0217710008	Tumor	0.3
CPT0205670004	Tumor	0.3
CPT0189750004	Tumor	0.3
CPT0093590003	Tumor	0.2
CPT0224540004	Tumor	0.2
CPT0125510003	Tumor	0.2
CPT0217060003	Tumor	0.2
CPT0127420003	Tumor	0.2
CPT0205570003	Tumor	0.2
CPT0162100003	Tumor	0.2
CPT0208980003	Tumor	0.2
CPT0123530003	Tumor	0.2
CPT0168270003	Tumor	0.1
CPT0175060003	Tumor	0.1
CPT0162020003	Tumor	0.1
CPT0171580008	Tumor	0.1
CPT0218960004	Tumor	0.1
CPT0125220003	Tumor	0.1
CPT0167970003	Tumor	0.1
CPT0167860004	Tumor	0.1
CPT0228220003	Tumor	0.1
CPT0087570003	Tumor	0.1
CPT0161730003	Tumor	0.1
CPT0167750004	Tumor	0.1
CPT0168380003	Tumor	0.1
CPT0206670004	Tumor	0.1
CPT0205780003	Tumor	0.1
CPT0207090003	Tumor	0.1
CPT0168720003	Tumor	0.1
CPT0093360003	Tumor	0.0
CPT0189570004	Tumor	0.0
CPT0206880003	Tumor	0.0
CPT0218890004	Tumor	0.0
CPT0002410011	Tumor	0.0
CPT0219080004	Tumor	0.0
CPT0189650004	Tumor	0.0
CPT0087680003	Tumor	0.0
CPT0225730003	Tumor	0.0
CPT0087950003	Tumor	0.0
CPT0125570003	Tumor	0.0
CPT0189460003	Tumor	0.0
CPT0186100003	Tumor	0.0
CPT0217000004	Tumor	-0.1
CPT0064890003	Tumor	-0.1
CPT0093550003	Tumor	-0.1
CPT0207030003	Tumor	-0.1
CPT0064650003	Tumor	-0.1
CPT0217100003	Tumor	-0.1
CPT0182550003	Tumor	-0.1
CPT0209440003	Tumor	-0.1
CPT0092440003	Tumor	-0.1
CPT0167530003	Tumor	-0.1
CPT0201710003	Tumor	-0.1
CPT0196850003	Tumor	-0.2
CPT0206780003	Tumor	-0.2
CPT0204400003	Normal	-0.2
CPT0216920008	Tumor	-0.2
CPT0199770003	Tumor	-0.2
CPT0182500003	Tumor	-0.2
CPT0217190003	Tumor	-0.2
CPT0205890003	Tumor	-0.2
CPT0206110003	Tumor	-0.2
CPT0089150003	Tumor	-0.2
CPT0206330003	Tumor	-0.2
CPT0162140003	Tumor	-0.2
CPT0189850004	Tumor	-0.3
CPT0071100003	Tumor	-0.3
CPT0218670003	Tumor	-0.3
CPT0206450003	Tumor	-0.3
CPT0224600003	Tumor	-0.3
CPT0087730003	Tumor	-0.4
CPT0104330003	Tumor	-0.4
CPT0204380003	Normal	-0.4
CPT0204420003	Normal	-0.4
CPT0204360003	Normal	-0.4
CPT0204390003	Normal	-0.5
CPT0104220003	Tumor	-0.5
CPT0218770003	Tumor	-0.5
CPT0204350003	Normal	-0.5
CPT0204340003	Normal	-0.5
CPT0204410003	Normal	-0.6
CPT0224330003	Tumor	-0.6
CPT0189250003	Tumor	-0.6
CPT0204330003	Normal	-0.7
CPT0190240004	Tumor	-0.8
CPT0204370003	Normal	-0.8
Show allShow less

GLIOMA - Protein expressionⁱ A mouse-over function shows sample information and annotation data. Click on an image to view it in a full screen mode. Samples can be filtered based on level of antibody staining by selecting one or several of the following categories: high, medium, low and not detected. The assay and annotation is described here. Note that samples used for immunohistochemistry by the Human Protein Atlas do not correspond to samples in the TCGA dataset.

Antibody stainingⁱ Antibody staining in the annotated cell types in the current human tissue is reported as not detected, low, medium, or high, based on conventional immunohistochemistry profiling in selected tissues. This score is based on the combination of the staining intensity and fraction of stained cells. Each image is clickable and will lead to virtual microscopy that enables deeper exploration of all samples and also displays staining intensity scores, fraction scores and subcellular localization as well as patient and tissue information for each sample.	Antibody HPA011311	Antibody CAB010339
Staining
High
Medium
Low
Not detected
Intensity
Strong
Moderate
Weak
Negative
Quantity
>75%
75%-25%
<25%
None
Location
Nuclear
Cytoplasmic/membranous
Cytoplasmic/membranous,nuclear
None
Glioma, malignant, High grade
Glioma, malignant, Low grade